ロード中...
Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways
Chemoresistance due to heterogeneity of the tumor microenvironment (TME) hampers the long-term efficacy of frontline therapies for lung cancer. Current combination therapies for lung cancer provide only modest improvement in survival, implicating necessity for novel approaches that suppress malignan...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854493/ https://ncbi.nlm.nih.gov/pubmed/24085788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0987 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|